Page last updated: 2024-08-23

propiconazole and thalidomide

propiconazole has been researched along with thalidomide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cox, MC; Lionetto, L; Mannino, G; Naso, V; Simmaco, M; Spiriti, MA1
Han, H; Huang, J; Ma, L; Peng, F; Zhang, C; Zhang, X1
Chen, CI; Chu, CM; Cserti-Gazdewich, C; Jiang, H; Jimenez-Zepeda, VH; Kukreti, V; Masih-Khan, E; Rabea, A; Reece, DE; Tiedemann, R; Trudel, S; Tsang, R1

Other Studies

3 other study(ies) available for propiconazole and thalidomide

ArticleYear
Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?
    American journal of hematology, 2011, Volume: 86, Issue:11

    Topics: Aged; Antineoplastic Agents; Central Nervous System Neoplasms; Chromatography, Liquid; Humans; Lenalidomide; Lymphoma, Mantle-Cell; Magnetic Resonance Imaging; Male; Orbit; Tandem Mass Spectrometry; Thalidomide

2011
Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.
    Endocrine, 2012, Volume: 41, Issue:2

    Topics: 3T3-L1 Cells; Adipocytes, White; Adipogenesis; Animals; Cells, Cultured; Down-Regulation; Fatty Acid-Binding Proteins; Fibroblasts; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Interleukin-6; Mice; Orbit; Osmolar Concentration; PPAR gamma; Receptors, Thyrotropin; RNA, Messenger; Thalidomide; Tumor Necrosis Factor-alpha

2012
Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.
    British journal of haematology, 2013, Volume: 162, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Central Nervous System; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Injections, Spinal; Kaplan-Meier Estimate; Lenalidomide; Male; Meninges; Middle Aged; Multiple Myeloma; Orbit; Proportional Hazards Models; Pyrazines; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Spine; Thalidomide; Transplantation, Autologous; Treatment Outcome; Vincristine

2013